We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drug Developers Urged to Adopt Humans as Superorganism Approach

By LabMedica International staff writers
Posted on 26 Jul 2012
A recent review article summarized more than 100 studies relating to the concept that humans are actually “superorganisms” composed of many varieties of eukaryotic and prokaryotic cells.

Most drug development activities have been conducted within a framework that links a single drug with its critical receptor target. More...
However, this approach may change due to increasing interest in understanding the properties of traditional Chinese medicines (TCMs) for their potential utilization as a source of new drugs, since emerging evidence indicates that most TCM drugs are actually targeting both the human host and many of its symbiotic microbes.

Chinese medicine traditionally viewed humans as “superorganisms” comprised of only about 10% human cells with the other 90% of the body being composed of bacterial, fungal, and other cells. These symbiotic microorganisms release molecular signals that can determine whether human genes turn on or off and that can influence the immune system's defenses against disease.

To better understand the superorganism concept investigators at Shanghai Jiao Tong University (Shanghai, China) reviewed more than 100 studies related to this topic in a paper that was published in the July 6, 2012, issue of the Journal of Proteome Research. In this review, they explored the challenges of and opportunities for harmonizing Eastern–Western drug discovery paradigms by focusing on emergent functions at the whole body level of humans as superorganisms.

“This superorganism view of the human body provides a complete new systems concept for managing human health at the clinically relevant whole body level,” said the authors. “It is one of the most significant paradigm shifts in modern medicine."

The review described how this revolutionary change is fostering emergence of an approach called "functional metagenomics" for developing new medicines. This could lead to new drug candidate compounds for chronic diseases targeting receptors outside the currently accepted “druggable genome” and shed light on current high interest issues in Western medicine such as drug-drug and drug-diet-gut microbial interactions that will be crucial in the development and delivery of future therapeutic regimes optimized for the individual patient.

Related Links:

Shanghai Jiao Tong University





Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.